Information on doctor and pharmacy shopping for opioids adds little to the identification of presumptive opioid abuse disorders in health insurance claims data

References

• Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613–2620. doi:10.1001/jama.2008.80219066381
   PubMed Web of Science ®Google Scholar
• Paulozzi LJ, Kilbourne EM, Shah NG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13(1):87–95. doi:10.1111/j.1526-4637.2011.01260.x22026451
   PubMed Web of Science ®Google Scholar
• Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled substances. Med Care. 2012;50(6):494–500. doi:10.1097/MLR.0b013e31824ebd8122410408
   PubMed Web of Science ®Google Scholar
• Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174(5):796–801. doi:10.1001/jamainternmed.2013.1271124589873
   PubMed Web of Science ®Google Scholar
• White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care. 2009;15(12):897–906.20001171
   PubMed Web of Science ®Google Scholar
• Sullivan MD, Edlund MJ, Fan M-Y, Devries A, Brennan Braden J, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study. Pain. 2010;150:332–339. doi:10.1016/j.pain.2010.05.02020554392
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Fife D, Kihm MA, Mastrogiovanni G, Yuan Y. Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse. Clin J Pain. 2014;30(12):1051–1056. doi:10.1097/AJP.000000000000006724370606
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. New safety measures announced for extended-release and long-acting opioids. Updated 115, 2017 Available from: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm363722.htm, Accessed 811, 2017
   Google Scholar
• US Food and Drug Administration. Sentinel common data model. Available from: https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model/sentinel-common-data-model. Accessed 5 5, 2018
   Google Scholar
• Walker AM, Weatherby LB, Cepeda MS, Bradford D, Yuan Y. Possible opioid shopping and its correlates. Clin J Pain. 2017;33(11):976–982. doi:10.1097/AJP.000000000000048328145912
   PubMed Web of Science ®Google Scholar
• Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage. 2001;22(2):672–687.11495714
   PubMed Web of Science ®Google Scholar
• Carman WJ, Su S, Cook SF, Wurzelmann JI, McAfee A. Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort. Pharmacoepidemiol Drug Saf. 2011;20(7):754–762. doi:10.1002/pds.213121567652
   PubMed Web of Science ®Google Scholar
• Katz NP, Birnbaum HG, Castor A. Volume of prescription opioids used nonmedically in the United States. J Pain Palliat Care Pharmacother. 2010;24(2):141–144. doi:10.3109/1536028100379909820504136
   PubMedGoogle Scholar
• Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373(18):1789–1790. doi:10.1056/NEJMc1505541
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Kasper ZA. Increased use of heroin as an initiating opioid of abuse. Addict Behav. 2017;74:63–66. doi:10.1016/j.addbeh.2017.05.03028582659
   PubMed Web of Science ®Google Scholar
• Kariisa M, Scholl L, Wilson N, Seth P, Hoots B. Drug overdose deaths involving cocaine and psychostimulants with abuse potential — United States, 2003–2017. MMWR Morb Mortal Wkly Rep. 2019;68:388–395. 10.15585/mmwr.mm6817a3external icon. doi:10.15585/mmwr.mm6805a431048676
   PubMed Web of Science ®Google Scholar
• Barocas JA, Wang J, Marshall BDL, et al. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019;8(200):59–63. doi:10.1016/j.drugalcdep.2019.03.014
   Web of Science ®Google Scholar
• Katz N, Panas L, Kim M, et al. Usefulness of prescription monitoring programs for surveillance–analysis of Schedule II opioid prescription data in Massachusetts, 19962006. Pharmacoepidemiol Drug Saf. 2010;19(2):115–123. doi:10.1002/pds.187820014166
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US. Drug Saf. 2012;35(4):325–334. doi:10.2165/11596600-000000000-0000022339505
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC. Opioid shopping behavior: how often, how soon, which drugs, and what payment method. J Clin Pharmacol. 2013;53(1):112–117. doi:10.1177/009127001243656123400751
   PubMed Web of Science ®Google Scholar
• Chilcoat HD, Coplan PM, Harikrishnan V, Alexander L. Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin). Drug Alcohol Depend. 2016;1(165):221–228. doi:10.1016/j.drugalcdep.2016.06.009
   Web of Science ®Google Scholar
• Green CA, Perrin NA, Hazelhurst B, et al. Identifying and classifying opioid-related overdoses: a validation study. Pharmacoepidemiol Drug Saf. 2019; doi:10.1002/pds.4772 Epub ahead of print.
   Web of Science ®Google Scholar
• Roland CL, Lake J, Oderda GM. Prevalence of prescription opioid abuse/abuse as determined by international classification of diseases codes: a systematic review. J Pain Palliat Care Pharmacother. 2016;30(4):258–268. doi:10.1080/15360288.2016.123173927802072
   PubMed Web of Science ®Google Scholar
• Mojtabai R, Amin-Esmaeili M, Nejat E, Olfson M. Abuse of prescribed opioids in the United States. Pharmacoepidemiol Drug Saf. 2019;28(3):345–353. doi:10.1002/pds.474330723973
   PubMed Web of Science ®Google Scholar